Convallatoxin inhibits IL‐1β production by suppressing zinc finger protein 91 (ZFP91)‐mediated pro‐IL‐1β ubiquitination and caspase‐8 inflammasome activity. (23rd February 2022)

• Record Type: Journal Article
• Authors: Xing, Yue; Wang, Jing Ying; Li, Ming Yue; Zhang, Zhi Hong; Jin, Hong Lan; Zuo, Hong Xiang; Ma, Juan; Jin, Xuejun
• Other Names: Mauro Claudio guestEditor.; Naylor Amy guestEditor.; Lord Janet M. guestEditor.
• Is Part Of: British journal of pharmacology. Volume 179:Number 9(2022)
• Page Start: 1887
• Page End: 1907
• Publication Date: 2022-02-23
• Subjects: convallatoxin -- IL‐1β -- inflammasome -- polyubiquitination -- ZFP91; Pharmacology -- Periodicals; Chemotherapy -- Periodicals; Drug Therapy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1111/bph.15758
• Languages: English
• ISSNs: 0007-1188

Abstract

Abstract : Background and Purpose: ZFP91 positively regulates IL‐1β production in macrophages and may be a potential therapeutic target to treat inflammatory‐related diseases. We investigated whether this process is modulated by convallatoxin, which is a cardiac glycoside isolated from the traditional Chinese medicinal plant Adonis amurensis Regel et Radde . Experimental Approach: In vitro, the mechanisms by which convallatoxin inhibits ZFP91‐regulated IL‐1β expression were investigated using molecular docking, western blotting, RT‐PCR, ELISA, immunofluorescence and immunoprecipitation assays. In vivo, mice liver injury was induced by an intraperitoneal injection of D‐GalN and LPS, colitis was induced by oral administration of dextran sulfate sodium (DSS) in drinking water and peritonitis was induced by an intraperitoneal injection of alum. Key Results: We confirmed that convallatoxin inhibited the release of IL‐1β by down‐regulating ZFP91. Importantly, we found that convallatoxin significantly reduced K63‐linked polyubiquitination of pro‐IL‐1β regulated by ZFP91 and decreased the efficacy of pro‐IL‐1β cleavage. Moreover, convallatoxin suppressed ZFP91‐mediated activation of the non‐canonical cysteine‐requiring aspartate protease‐8 (caspase‐8) inflammasome and MAPK signalling pathways in macrophages. Furthermore, we showed that ZFP91 promoted the assembly of the caspase‐8 inflammasome complex, whereas convallatoxin treatment reversed this result. Mice in vivo studies further demonstrated that convallatoxin ameliorated D‐GalN/LPS‐induced liver injury, DSS‐induced colitis and alum‐induced peritonitis by down‐regulating ZFP91. Conclusion and Implications: We show for the first time that convallatoxin‐mediated inhibition of ZFP91 is an important regulatory event that prevents inappropriate inflammatory responses to maintain immune homeostasis. This mechanism provides new insight for the development of convallatoxin as a novel anti‐inflammatory drug targeting ZFP91. LINKED ARTICLES: This article is part of a themed issue on Inflammation, Repair and Ageing. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.9/issuetoc